Geerdink, Jasper X.
van der Wal, Greetje
de Jong, Lutea A. A.
Olyslager, Erik J. H.
van den Goorbergh, Thomas W.
Kluijtmans, Leo A. J.
Spronk, Peter E.
Article History
Received: 18 November 2024
Accepted: 22 February 2025
First Online: 7 March 2025
Declarations
:
: The patient provided consent for treatment after initially being unconscious, during which time treatment was administered based on what was deemed to be in the patient’s best interest. Upon regaining consciousness, the patient explicitly consented to continued treatment with levocarnitine.
: Patient granted permission for publication, a signed consent form available on request.
: The authors declare no competing interests.